| | | | | | | | | Sponsored | | Respiratory season starts long before samples arrive. As testing volumes increase, a reliable quality control strategy becomes even more important. Now is the time to review your QC approach and prepare with third-party molecular respiratory controls designed to help monitor assay performance, support confidence in results, and keep your laboratory ready for the season ahead. |
|
|
| | |
| |
| | |
|
|
| | | | | | New research published in Nature sheds light on viral reactivation during COVID-19, finding that Herpesviridae and Anelloviridae reactivation was common among hospitalized patients and that Anelloviridae was associated with long COVID. |
|
|
| | An Illinois-headquartered healthcare system has settled with the U.S. Department of Health and Human Services (HHS), Office for Civil Rights (OCR) over potential HIPAA violations resulting in the compromising of nearly 54,000 patients’ protected health information (PHI). |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Roche Lab Automation now connects to an ever-expanding ecosystem of Roche and certified third-party instruments. Curate your ideal test menu and workflow from a broad list of industry partners, delivering more flexibility. |
|
|
| | |
| |
| | |
|
|
| | | | | | Join our free CE webinars to explore cutting-edge topics like STI diagnostics, stroke care improvements, blood biomarkers for Alzheimer's, and digital microscopy, enhancing your clinical expertise and patient outcomes. |
|
|
|
| |
| | |
|
|
| | | | | | Artera has begun enrolling patients in the DIRECT-AI registry study, a nationwide effort to assess the clinical utility of its AI-powered prostate cancer test, aiming to inform treatment decisions and improve patient outcomes. |
|
|
|
| |
| | |
|
|
| | | | | | Calla Lily Clinical Care will evaluate its proprietary Callavid drug delivery platform as part of Wellcome Leap’s Focused Antibiotics program, exploring vaginal delivery of antibiotics for UTIs while reducing systemic exposure and impacts on the gut microbiome. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|